BELLERI, Mirella
 Distribuzione geografica
Continente #
NA - Nord America 6.427
EU - Europa 3.032
AS - Asia 2.585
SA - Sud America 441
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 80
OC - Oceania 19
Totale 12.784
Nazione #
US - Stati Uniti d'America 6.242
PL - Polonia 1.071
CN - Cina 857
SG - Singapore 825
UA - Ucraina 414
DE - Germania 386
BR - Brasile 355
IT - Italia 297
HK - Hong Kong 266
VN - Vietnam 202
FI - Finlandia 193
GB - Regno Unito 164
FR - Francia 126
RU - Federazione Russa 109
IN - India 94
BD - Bangladesh 93
CA - Canada 79
TR - Turchia 78
IE - Irlanda 71
ES - Italia 52
ID - Indonesia 29
SE - Svezia 29
ZA - Sudafrica 28
AR - Argentina 24
CZ - Repubblica Ceca 24
JP - Giappone 22
MX - Messico 20
CR - Costa Rica 19
LT - Lituania 19
AU - Australia 18
IL - Israele 18
IQ - Iraq 16
NL - Olanda 16
JM - Giamaica 15
CL - Cile 14
EC - Ecuador 14
VE - Venezuela 13
AT - Austria 12
CO - Colombia 11
MA - Marocco 10
PH - Filippine 10
BE - Belgio 9
GP - Guadalupe 8
NG - Nigeria 8
PK - Pakistan 8
SA - Arabia Saudita 8
IR - Iran 7
KE - Kenya 7
SC - Seychelles 7
TN - Tunisia 7
GT - Guatemala 6
NI - Nicaragua 6
PR - Porto Rico 6
EE - Estonia 5
HN - Honduras 5
HU - Ungheria 5
PT - Portogallo 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
JO - Giordania 4
KR - Corea 4
KZ - Kazakistan 4
MY - Malesia 4
PE - Perù 4
PY - Paraguay 4
TH - Thailandia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
HR - Croazia 3
LB - Libano 3
LK - Sri Lanka 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
KG - Kirghizistan 2
MU - Mauritius 2
NO - Norvegia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BM - Bermuda 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 12.577
Città #
Warsaw 1.070
Ashburn 648
Fairfield 581
Singapore 461
Woodbridge 384
San Jose 347
Jacksonville 303
Houston 300
Hong Kong 263
Ann Arbor 251
Cambridge 234
Chandler 220
Seattle 208
Beijing 197
Council Bluffs 188
Wilmington 184
Dallas 155
Princeton 129
The Dalles 124
Los Angeles 119
Helsinki 118
New York 113
Nanjing 105
Brescia 90
Dublin 71
Istanbul 65
Lauterbourg 65
Dearborn 64
Santa Clara 61
Dong Ket 60
Munich 59
Columbus 56
San Francisco 46
Ho Chi Minh City 43
Madrid 39
São Paulo 39
Milan 38
Buffalo 37
Chicago 37
Boardman 36
Des Moines 34
Nanchang 32
Shanghai 31
Hanoi 30
Lancaster 30
Orem 29
Jinan 27
San Diego 27
Hebei 26
Moscow 25
North Bergen 25
Phoenix 24
Changsha 23
Redondo Beach 23
Shenyang 23
London 22
Jakarta 20
Tianjin 20
Tokyo 20
Brooklyn 19
Rio de Janeiro 19
Turku 19
Toronto 18
Atlanta 17
Johannesburg 17
Brno 16
Montreal 16
Boston 15
Chennai 15
San José 15
Stockholm 15
Washington 15
Guangzhou 14
Jiaxing 14
San Mateo 13
Vilnius 12
Lanzhou 11
Ningbo 11
Nuremberg 11
Rome 11
Charlotte 10
Denver 10
Kingston 10
Las Vegas 10
Da Nang 9
Frankfurt am Main 9
Kunming 9
Newark 9
Paris 9
Zhengzhou 9
Brussels 8
Haikou 8
Hangzhou 8
Mumbai 8
Porto Alegre 8
Redwood City 8
Abuja 7
Dhaka 7
Miami 7
Naples 7
Totale 8.582
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 420
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 386
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 343
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 337
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 312
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 302
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 300
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 295
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 278
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 243
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 236
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 233
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 230
Anti-angiogenic activity of the purine analog 6-thioguanine. 226
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 220
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 219
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 219
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 218
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 213
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 199
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 193
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 191
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 191
Beta-Galactosylceramidase deficiency: neurovascular implications 187
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 183
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 181
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 171
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 169
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 166
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 162
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 156
A novel ex vivo murine retina angiogenesis (EMRA) assay 154
In vitro and ex vivo retina angiogenesis assays 154
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 153
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 152
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 152
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. 150
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. 149
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 146
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 146
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 145
Non competitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation 144
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 144
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. 143
Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells: an in vitro autocrine model of angiogenesis in brain tumors 142
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 142
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 141
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 140
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 140
Undersulfated and glycol-split heparins endowed with antiangiogenic activity 140
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 140
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 138
Role of inflammation in FGF2-driven angiogenesis 136
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 135
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 134
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 133
Endothelial cell dysfunction in globoid cell leukodystrophy 130
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos 127
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 127
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 122
The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis 122
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 122
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 119
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 109
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 109
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 105
In Vitro and In Vivo Efficacy on Retinal Neo-Vascularization of an Innovative Broad-Range Anti-Angiogenic Synthetic Peptide (Uparant) 99
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 97
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process 93
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 88
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist 85
Integrin -dependent antiangiogenic activity of resveratrol stereoisomers 82
β-Galactosylceramidase in cancer: more than a psychosine scavenger 54
Involvement of N-formyl peptide receptors in modulating the pro-angiogenic/pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (PDR) 22
Totale 12.784
Categoria #
all - tutte 53.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022431 0 0 0 0 12 25 36 30 26 105 53 144
2022/2023554 88 31 26 44 50 135 6 49 70 4 24 27
2023/2024719 47 41 106 26 42 107 33 21 136 34 19 107
2024/20251.358 18 11 5 193 130 142 117 65 153 82 264 178
2025/20263.213 311 366 291 443 347 220 457 117 181 260 143 77
2026/20271.110 133 135 223 425 194 0 0 0 0 0 0 0
Totale 12.784